Your Messages Inbox
Your Article Summary
See Latest ArticlesReport Shows Buffalo Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases
PhRMA, 09/21/09
Twenty–eight innovative medicines are being developed by biopharmaceutical research companies with facilities in Buffalo, according to a new report released at the Hauptman Woodward Medical Research Institute. The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
BayNews International, 12/02/09
Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09
Article Search
Sponsor